Literature DB >> 16533485

Vertebrobasilar insufficiency.

Arockia Doss1, Constantine C Phatouros.   

Abstract

Vertebrobasilar insufficiency presents with characteristic symptoms and signs due to impaired perfusion of the cerebellum, the brain stem, and the occipital cortex. This may be due to reduced perfusion usually due to atherosclerosis or thromboembolism. Choice of treatment depends on understanding the different underlying pathophysiologic mechanisms. Antiplatelet therapy; reduction of risk factors such as diabetes, hypertension, hypercholesterolemia, and cigarette smoking; and a healthy lifestyle form the first line of management. Systemic anticoagulation in the short term also has a key role in selected cases. In patients with refractory symptoms on maximal medical therapy and underlying focal stenotic lesions, endovascular revascularization using stents and balloon angioplasty may be indicated. Bypass surgery is another option if there are factors that render endovascular therapy unsuitable.

Entities:  

Year:  2006        PMID: 16533485     DOI: 10.1007/s11936-006-0003-0

Source DB:  PubMed          Journal:  Curr Treat Options Cardiovasc Med        ISSN: 1092-8464


  23 in total

1.  Classification and natural history of clinically identifiable subtypes of cerebral infarction.

Authors:  J Bamford; P Sandercock; M Dennis; J Burn; C Warlow
Journal:  Lancet       Date:  1991-06-22       Impact factor: 79.321

2.  Symptomatic intracranial atherosclerosis: outcome of patients who fail antithrombotic therapy.

Authors:  V N Thijs; G W Albers
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

3.  A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

Authors: 
Journal:  Lancet       Date:  1996-11-16       Impact factor: 79.321

4.  Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial.

Authors:  Helen M Colhoun; D John Betteridge; Paul N Durrington; Graham A Hitman; H Andrew W Neil; Shona J Livingstone; Margaret J Thomason; Michael I Mackness; Valentine Charlton-Menys; John H Fuller
Journal:  Lancet       Date:  2004 Aug 21-27       Impact factor: 79.321

5.  A reappraisal of angioplasty and stenting for the treatment of vertebral origin stenosis.

Authors:  Felipe C Albuquerque; David Fiorella; Patrick Han; Robert F Spetzler; Cameron G McDougall
Journal:  Neurosurgery       Date:  2003-09       Impact factor: 4.654

6.  The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.

Authors:  J Bogousslavsky; G Van Melle; F Regli
Journal:  Stroke       Date:  1988-09       Impact factor: 7.914

Review 7.  Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation.

Authors:  L Jones; S Griffin; S Palmer; C Main; V Orton; M Sculpher; C Sudlow; R Henderson; N Hawkins; R Riemsma
Journal:  Health Technol Assess       Date:  2004-10       Impact factor: 4.014

Review 8.  Endovascular treatment of cerebrovascular diseases and intracranial neoplasms.

Authors:  Adnan I Qureshi
Journal:  Lancet       Date:  2004-03-06       Impact factor: 79.321

9.  North American clinical experience with the EKOS MicroLysUS infusion catheter for the treatment of embolic stroke.

Authors:  Brian R Mahon; Gary M Nesbit; Stanley L Barnwell; Wayne Clark; Thomas R Marotta; Alain Weill; Phillip A Teal; Adnan I Qureshi
Journal:  AJNR Am J Neuroradiol       Date:  2003-03       Impact factor: 3.825

10.  Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.

Authors:  John Chalmers; Stephen MacMahon
Journal:  J Hypertens Suppl       Date:  2003-06
View more
  3 in total

1.  The assessment value of transcranial Doppler sonography versus magnetic resonance angiography in vertebrobasilar stroke.

Authors:  Abbas Ghorbani; Fereshteh Ashtari; Farzad Fatehi
Journal:  J Res Med Sci       Date:  2010-05       Impact factor: 1.852

2.  The association between vertebrobasilar insufficiency and the risk of dementia: a nationwide register-based retrospective cohort study in Taiwan.

Authors:  Fu-Chi Yang; Shao-Yuan Chen; Jiu-Haw Yin; Chun-Chieh Lin; Yueh-Feng Sung; Chung-Hsing Chou; Chi-Hsiang Chung; Wu-Chien Chien; Chia-Kuang Tsai; Chia-Lin Tsai; Guan-Yu Lin; Jiunn-Tay Lee
Journal:  BMJ Open       Date:  2017-08-23       Impact factor: 2.692

3.  The diagnosis of vertebrobasilar insufficiency using transcranial Doppler ultrasound.

Authors:  Ibrahim Alnaami; Muzaffer Siddiqui; Maher Saqqur
Journal:  Case Rep Med       Date:  2012-11-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.